ARTICLE | Company News
Inex cancer, gene/cell therapy news
January 29, 2001 8:00 AM UTC
IEX transferred its stable plasmid-lipid particle (SPLP) targeted gene delivery technology to Protiva Biotherapeutics Inc., a newly formed subsidiary. Protiva will apply the technology to protein the...